Pityriasis versicolor: A review of pharmacological treatment options

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 2, 2005, Pages 165-178

  Gupta, Aditya K ^a,b,c   Kogan, Nataly ^b   Batra, Roma ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c NONE   (Canada)

Author keywords

Antifungal; Malassezia; Pityriasis versicolor

Indexed keywords

ANTIFUNGAL AGENT; BENZOIC ACID; BENZOYL PEROXIDE; BIFONAZOLE; CICLOPIROX; CICLOPIROXOLAMINE; CLOTRIMAZOLE; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; FLUTRIMAZOLE; ISOCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MICONAZOLE NITRATE; OXICONAZOLE; PLACEBO; PROPYLENE GLYCOL; PYRITHIONE ZINC; SALICYLIC ACID; SELENIUM SULFIDE; SERTACONAZOLE; SULFUR; TERBINAFINE; TIOCONAZOLE; WHITFIELD OINTMENT;

CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG EXCRETION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FLUORESCENCE ANALYSIS; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INFECTION PREVENTION; LIPOPHILICITY; MALASSEZIA; MEDICAL DECISION MAKING; MICROSCOPY; NONHUMAN; REVIEW; SIDE EFFECT; SKIN DEFECT; SKIN DISEASE; TINEA VERSICOLOR; TREATMENT PLANNING;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; CLINICAL TRIALS; HUMANS; MALASSEZIA; RECURRENCE; SKIN; TINEA VERSICOLOR;

EID: 14544299587     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.2.165     Document Type: Review

References (132)

1. CRESPO EV, DELGADO FV: Malassezia species in skin diseases. Curr. Opin. Infect. Dis. (2002) 15(2):133-142.
2. MIDGLEY G: The lipophilic yeasts: state of the art and prospects. Med. Mycol. (2000) 38(Suppl.):19-16.
3. BORELLI D, JACOBS PH, NALL L: Tinea versicolor: epidemiologic, clinical, and therapeutic aspects. J. Am. Acad. Dermatol. (1991) 25(2 Pt 1):300-305.
4. MELLEN LA, VALLEE J, FELDMAN SR, FLEISCHER AB Jr: Treatment of pityriasis versicolor in the United States. J. Dermatolog. Treat. (2004) 15(3):189-192.
5. FAERGEMANN J: Pityrosporum species as a cause of allergy and infection. Allergy (1999) 54(5):413-419.
6. ZUBER TJ, BADDAM K: Superficial fungal infection of the skin. Where and how it appears help determine therapy. Postgrad. Med. (2001) 109(1):117-120, 123-126, 131-132.
7. GORDON MA: Lipophilic yeastlike organisms associated with tinea versicolor. J. Invest. Dermatol. (1951) 17(5 ):267-272.
8. GUPTA AK, COOPER EA, RYDER JE, NICOL KA, CHOW M, CHAUDHRY MM: Optimal management of fungal infections of the skin, hair, and nails. Am. J. Clin. Dermatol. (2004) 5(4):225-237.
9. SCHWARTZ RA: Superficial fungal infections. Lancet (2004) 364(9440):1173-1182.
10. SOHNLE PG, COLLINS-LECH C: Relative antigenicity of P. orbiculare and C. albicans. J. Invest. Dermatol. (1980) 75 3):279-283.
11. ASHBEE HR, INGHAM E, HOLLAND KT, CUNLIFFE WJ: Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp. Dermatol. (1994) 3(3):106-112.
12. BERGBRANT IM, ANDERSSON B, FAERGEMANN J: Cell-mediated immunity to Malassezia furfur in patients with seborrhoeic dermatitis and pityriasis versicolor. Clin. Exp. Dermatol. (1999) 24 5):402-406.
13. NEUBER K, KROGER S, GRUSECK E, ABECK D, RING J: Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN gamma) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch. Dermatol. Res. (1996) 288(9):532-536.
14. SOHNLE PG, COLLINS-LECH C: Cell-mediated immunity to Pityrosporum orbiculare in tinea versicolor. J. Clin. Invest. (1978) 62(1):45-53.
15. WU YC, CHEN KT: Humoral immunity in patients with tinea versicolor. J. Dermatol. (1985) 12(2):161-166.
16. FAERGEMANN J: Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages. J. Invest. Dermatol. (1983) 80(2):133-135.
17. STERNBERG TH, KEDDIE FM: Immunofluorescence studies in tinea versicolor. A preliminary report. Arch. Dermatol. (1961)84 999-1003.
18. MCGINLEY KJ, LANTIS LR, MARPLES RR: Microbiology of tinea versicolor. Arch. Dermatol. (1970) 102(2):168-171.
19. BURKE RC: Tinea versicolor: susceptibility factors and experimental infection in human beings. J. Invest. Dermatol. (1961)36:389-402.
20. SILVA-LIZAMA E: Tinea versicolor. Int. J. Dermatol. (1995) 34(9):611-617.
21. CATTERALL MD, WARD ME, JACOBS P: A reappraisal of the role of Pityrosporum orbiculare in pityriasis versicolor and the significance of extracellular lipase. J. Invest. Dermatol. (1978) 71 6):398-401.
22. GUPTA AK, KOHLI Y, SUMMERBELL RC, FAERGEMANN J: Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med. Mycol. (2001) 39(3 ):243-251.
23. TARAZOOIE B, KORDBACHEH P, ZAINI F et al.: Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran. BMC Dermatol. (2004) 4 1):5.
24. CRESPO-ERCHIGA V, MARTOS AO, CASANO AV, CRESPO-ERCHIGA A, SANCHEZ-FAJARDO F, GUEHO E: Mycology of pityriasis versicolor. J. Mycol. Med. (1999) 9:143-148.
25. ASPIROZ C, ARA M, VAREA M, REZUSTA A, RUBIO C: Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia (2002) 154(3):111-117.
26. MAYSER P, GROSS A: IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens. Acta Derm. Venereol. (2000) 80(5):357-361.
27. HATTORI M, OGAWA H, TAKAMORI K, GRITIYARANSON P, KOTARAJARAS R: De-(hypo)pigmentation mechanisms of the affected area of Pityriasis versicolor. J. Dermatol. (1984) 11(1):63-66.
28. TOSTI A, VILLARDITA S, FAZZINI ML: The parasitic colonization of the horny layer in tinea versicolor. J. Invest. Dermatol. (1972) 59(3):233-237.
29. ALLEN HB, CHARLES CR, JOHNSON BL: Hyperpigmented tinea versicolor. Arch. Dermatol. (1976) 112(8):1110-1112.
30. KARAOUI R, BOU-RESLI M, AL ZAID NS, MOUSA A: Tinea versicolor: ultrastructural studies on hypopigmented and hyperpigmented skin. Dermatologica (1981) 162(2):69-85.
31. GALADARI I, EL KOMY M, MOUSA A, HASHIMOTO K, MEHREGAN AH: Tinea versicolor: histologic and ultrastructural investigation of pigmentary changes. Int. J. Dermatol. (1992) 31(4):253-256.
32. DOTZ WI, HENRIKSON DM, YU GS, GALEY CI: Tinea versicolor: a light and electron microscopic study of hyperpigmented skin. J. Am. Acad. Dermatol. (1985) 12(1 Pt 1):37-44.
33. CHARLES CR, SIRE DJ, JOHNSON BL, BEIDLER JG: Hypopigmentation in tinea versicolor: a histochemical and electronmicroscopic study. Int. J. Dermatol. (1973) 12(1):48-58.
34. MAYSER P, PAPE B: Decreased susceptibility of Malassezia furfur to UV light by synthesis of tryptophane derivatives. Antonie van Leeuwenhoek (1998) 73(4):315-319.
35. MAYSER P, STAPELKAMP H, KRAMER HJ et al.: Pityrialactone- a new fluorochrome from the tryptophan metabolism of Malassezia furfur. Antonie van Leeuwenhoek (2003) 84 3):185-191.
36. BLUMENTHAL HL: Tinea versicolor of penis. Arch. Dermatol. (1971) 103(4):461-462.
37. NAZZARO-PORRO M: Azelaic acid. J. Am. Acad. Dermatol. (1987) 17(6):1033-1041.
38. NAZZARO-PORRO M, PASSI S: Identification of tyrosinase inhibitors in cultures of Pityrosporum. J. Invest. Dermatol. (1978) 71(3):205-208.
39. NAZZARO-PORRO M, PASSI S, PICARDO M, MERCANTINI R, BREATHNACH AS: Lipoxygenase activity of Pityrosporum in vitro and in vivo. J. Invest. Dermatol. (1986) 87(1):108-112.
40. CHU AC: Comparative clinical trial of bifonazole solution versus selenium sulphide shampoo in the treatment of pityriasis versicolor. Dermatologica (1984) 169(Suppl.):181-186.
41. FAERGEMANN J, FREDRIKSSON T: An open trial of the effect of a zinc pyrithione shampoo in tinea versicolor. Cutis (1980) 25 6):667, 669.
42. VERMEER BJ, STAATS CC: The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study. Dermatology (1997) 194 Suppl.):122-124.
43. ROGERS CJ, COOK TF, GLASER DA: Diagnosing tinea versicolor: don't scrape, just tape. Pediatr. Dermatol. (2000) 17 1):68-69.
44. COHEN MM: A simple procedure for staining tinea versicolor (M. furfur) with fountain pen ink. J. Invest. Dermatol. (1954) 22(1):9-10.
45. SUNENSHINE PJ, SCHWARTZ RA, JANNIGER CK: Tinea versicolor: an update. Cutis (1998) 61(2):65-68.
46. HERSLE K: Selenium sulphide treatment of tinea versicolor. Acta Derm. Venereol. (1971) 51(6):476-478.
47. SANCHEZ JL, TORRES VM: Selenium sulfide in tinea versicolor: blood and urine levels. J. Am. Acad. Dermatol. (1984) 11(2 Pt 1):238-241.
48. KATSAMBAS A, RIGOPOULOS D, ANTONIOU C, ZACHARI A, FRAGOULI E, STRATIGOS J: Econazole 1% shampoo versus selenium in the treatment of tinea versicolor: a single-blind randomized clinical study. Int. J. Dermatol. (1996) 35(9):667-668.
49. KLIGMAN AM, LEYDEN JJ, STEWART R: New uses for benzoyl peroxide: a broad-spectrum antimicrobial agent. Int. J. Dermatol. (1977) 16(5):413-417.
50. PRESTIA AE: Topical benzoyl peroxide for the treatment of tinea versicolor. J. Am. Acad. Dermatol. (1983) 9(2 ):277-278.
51. FAERGEMANN J, FREDRIKSSON T: Antimycotic activity of propane-1,2-diol (propylene glycol). Sabouraudia (1980) 18 3):163-166.
52. FAERGEMANN J, FREDRIKSSON T: Propylene glycol in the treatment of tinea versicolor. Acta Derm. Venereol. (1980) 60 1):92-93.
53. CLAYTON R, DU VA, SAVAGE M: Double-blind trial of 1% clotrimazole cream and Whitfield ointment in the treatment of pityriasis versicolor. Arch. Dermatol. (1977) 113(6):849-850.
54. BAMFORD JT: Treatment of tinea versicolor with sulfur-salicylic shampoo. J. Am. Acad. Dermatol. (1983) 8 2):211-213.
55. FREDRIKSSON T, FAERGEMANN J: Double-blind comparison of a zinc pyrithione shampoo and its shampoo base in the treatment of tinea versicolor. Cutis (1983) 31(4):436-437.
56. LANGE DS, RICHARDS HM, GUARNIERI J et al.: Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. J. Am. Acad. Dermatol. (1998) 39(6):944-950.
57. SAVIN RC, HORWITZ SN: Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J. Am. Acad. Dermatol. (1986) 15(3):500-503.
58. ASTE N, PAU M, CORDARO CI, BIGGIO P: Double-blind study with fenticonazole or bifonazole lotions in pityriasis versicolor. Int. J. Clin. Pharmacol. Res. (1988) 8(4):271-273.
59. HAY RJ, ADRIAANS B, MIDGLEY G, ENGLISH JS, ZACHARY CB: A single application of bifonazole 1% lotion in pityriasis versicolor. Clin. Exp. Dermatol. (1987) 12(4):315.
60. MORA RG, GREER DL: Comparative efficacy and tolerance of 1% bifonazole cream and bifonazole cream vehicle in patients with tinea versicolor. Dermatologica (1984) 169(Suppl.):187-192.
61. SOYINKA F: Bifonazole in the treatment of fungal skin infections in the tropics: a clinical and mycological study. Curr. Med. Res. Opin. (1987) 10(6):390-396.
62. DEL PALACIO HA, LOPEZ GS, IGLESIAS DL: Short course bifonazole therapy in pityriasis versicolor. Clin. Exp. Dermatol. (1987) 12(4):270-272.
63. ALCHORNE MM, PASCHOALICK RC, FORJAZ MH: Comparative study of tioconazole and clotrimazole in the treatment of tinea versicolor. Clin. Ther. (1987) 9(4):360-367.
64. GIP L: The topical therapy of pityriasis versicolor with clotrimazole. Postgrad. Med. J. (1974) 50(Suppl.):159-160.
65. CLAYTON YM, CONNOR BL: Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. Br. J. Dermatol. (1973) 89(3):297-303.
66. SPIEKERMANN PH, YOUNG MD: Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent. Arch. Dermatol. (1976) 112(3):350-352.
67. TANENBAUM L, ANDERSON C, ROSENBERG MJ, AKERS W: 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study. Arch. Dermatol. (1984) 120(2):216-219.
68. VICIK GJ, MENDIONES M, QUINONES CA, THORNE EG: A new treatment for tinea versicolor using econazole nitrate 1.0 percent cream once a day. Cutis (1984) 33(6):570-571.
69. NASARRE J, UMBERT P, HERRERO E et al.: Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor. Arzneimittelforschung (1992) 42 5A):764-767.
70. HAROON TS, TAREEN MI, HAFIZ A, RIZWANA: An open study of tioconazole 1% dermal cream in patients with pityriasis versicolor. J. Pak. Med. Assoc. (1984) 34(12):361-362.
71. RIGOPOULOS D, KATSAMBAS A, ANTONIOU C, POLYDOROU D, VLACHOU M, STRATIGOS J: Tinea versicolor treated with fluconazole shampoo. Int. J. Dermatol. (1992) 31(9):664-665.
72. PETRANYI G, RYDER NS, STUTZ A: Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science (1984) 224(4654):1239-1241.
73. ASTE N, PAU M, PINNA AL, COLOMBO MD, BIGGIO P: Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses (1991) 34(7-8):353-357.
74. FAERGEMANN J, HERSLE K, NORDIN P: Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatology (1997) 194(Suppl.):119-121.
75. PALACIO-HERNANZ A, GUARRO-ARTIGAS J, FIGUERAS-SALVAT MJ, ESTEBAN-MORENO J, LOPEZ-GOMEZ S: Changes in fungal ultrastructure after short-course ciclopiroxolamine therapy in pityriasis versicolor. Clin. Exp. Dermatol. (1990) 15(2):95-100.
76. CORTE M, JUNG K, LINKER U, MARTINI H, SAPP-BONCELET I, SCHULZ H: [Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor]. Mycoses (1989) 32 4):200-203.
77. URCUYO FG, ZAIAS N: The successful treatment of pityriasis versicolor by systemic ketoconazole. J. Am. Acad. Dermatol. (1982) 6(1):24-25.
78. HAY RJ, MIDGELEY G: Short course ketoconazole therapy in pityriasis versicolor. Clin. Exp. Dermatol. (1984) 9 6):571-573.
79. SADEQUE JB, SHAHIDULLAH M, SHAH OR, KAMAL M: Systemic ketoconazole in the treatment of tinea versicolor. Int. J. Dermatol. (1995) 34(7):504-505.
80. HEERES J, BACKX LJ, VAN CUTSEM J: Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J. Med. Chem. (1984) 27(7):894-900.
81. FAERGEMANN J: In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare. Antimicrob. Agents Chemother. (1984) 26(5):773-774.
82. VAN CUTSEM J: In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. Chemotherapy (1992) 38(Suppl. 1):3-11.
83. ROBERTSON LI: Itraconazole in the treatment of widespread tinea versicolor. Clin. Exp. Dermatol. (1987) 12(3 ):178-180.
84. CAUWENBERGH G, DE DONCKER P, STOOPS K, DE DIER AM, GOYVAERTS H, SCHUERMANS V: Itraconazole in the treatment of human mycoses: review of three years of clinical experience. Rev. Infect. Dis. (1987) 9(Suppl. 1):S146-S152.
85. KOSE O, BULENT TH, RIZA GA, KURUMLU Z: Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. J. Dermatolog. Treat. (2002) 13 2):77-79.
86. BHOGAL CS, SINGAL A, BARUAH MC: Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. J. Dermatol. (2001) 28(10 ):535-539.
87. MONTERO-GEI F, ROBLES ME, SUCHIL P: Fluconazole versus itraconazole in the treatment of tinea versicolor. Int. J. Dermatol. (1999) 38(8):601-603.
88. PARTAP R, KAUR I, CHAKRABARTI A, KUMAR B: Single-dose fluconazole versus itraconazole in pityriasis versicolor. Dermatology (2004) 208(1):55-59.
89. FARSHCHIAN M, YAGHOOBI R, SAMADI K: Fluconazole versus ketoconazole in the treatment of tinea versicolor. J. Dermatolog. Treat. (2002)13:73-76.
90. AMER MA: Fluconazole in the treatment of tinea versicolor. Egyptian Fluconazole Study Group. Int. J. Dermatol. (1997) 36 12):940-942.
91. FAERGEMANN J: Pityrosporum infections. J. Am. Acad. Dermatol. (1994) 31(3 Pt 2):S18-S20.
92. FAERGEMANN J, GUPTA AK, AL MOFADI A, ABANAMI A, SHAREAAH AA, MARYNISSEN G: Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch. Dermatol. (2002) 138 1):69-73.
93. FAERGEMANN J, DJARV L: Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis (1982) 30(4):542-545, 550.
94. RAUSCH LJ, JACOBS PH: Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. Cutis (1984) 34(5):470-471.
95. VANDER STRATEN MR, HOSSAIN MA, GHANNOUM MA: Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor. Infect. Dis. Clin. North Am. (2003) 17(1):87-112.
96. GALIMBERTI RL, VILLALBA I, GALARZA S, RAIMONDI A, FLORES V: Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment. Rev. Infect. Dis. (1987) 9(Suppl. 1):S134-S138.
97. HICKMAN JG: A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J. Am. Acad. Dermatol. (1996) 34(5 Pt 1):785-787.
98. GUPTA AK, KATZ HI, SHEAR NH: Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J. Am. Acad. Dermatol. (1999) 41(2 Pt 1):237-249.
99. LOMAESTRO BM, PIATEK MA: Update on drug interactions with azole antifungal agents. Ann. Pharmacother. (1998) 32 9):915-928.
100. MICHALETS EL: Update: clinically significant cytochrome P450 drug interactions. Pharmacotherapy (1998) 18(1):84-112.
101. SHEAR N, DRAKE L, GUPTA AK, LAMBERT J, YANIV R: The implications and management of drug interactions with itraconazole, fluconazole and terbinafine. Dermatology (2000) 201 3):196-203.
102. SANCHEZ JL, TORRES VM: Double-blind efficacy study of selenium sulfide in tinea versicolor. J. Am. Acad. Dermatol. (1984) 11(2 Pt 1):235-238.
103. HERNANDEZ-PEREZ E: A comparison between one and two weeks' treatment with bifonazole in pityriasis versicolor. J. Am. Acad. Dermatol. (1986) 14(4):561-564.
104. GALIMBERTI R, BELLI L, GATTI JC, NEGRONI R, VIGNALE R: An open, multicentre assessment of the effectiveness of bifonazole in the treatment of tinea (pityriasis) versicolor. Pharmatherapeutica (1985) 4(2):109-112.
105. GALIMBERTI RL, BONINO M, FLORES V et al.: Ultra-short topical treatment of pityriasis versicolor with 2.5% bifonazole cream. Clin. Exp. Dermatol. (1993) 18(1):25-29.
106. HERNANDEZ-PEREZ E: A comparison between two different regimens of monthly application with bifonazole spray 1% in pityriasis versicolor. Int. J. Dermatol. (1990) 29(6):438-440.
107. SAVIN R, EISEN D, FRADIN MS, LEBWOHL M: Tinea versicolor treated with terbinafine 1% solution. Int. J. Dermatol. (1999) 38(11):863-865.
108. BUDIMULJA U, PAUL C: One-week terbinafine 1% solution in pityriasis versicolor: twice-daily application is more effective than once-daily. J. Dermatolog. Treat. (2002) 13(1):39-40.
109. HIRA SK, DIN SN, PATEL JS: Econazole 1% in the treatment of pityriasis versicolor in Zambia. J. Am. Acad. Dermatol. (1985) 12(3):580-581.
110. ZAIAS N, BATTISTINI F: Superficial mycoses: treatment with a new, broad-spectrum antifungal agent: 1% clotrimazole solution. Arch. Dermatol. (1977) 113(3):307-308.
111. CULLEN SI, GROST P, JACOBSON C, KANOF NB: Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. Clin. Ther. (1985) 7(5):574-583.
112. GUGNANI HC, AKPATA LE, GUGNANI MK, SRIVASTAVA R: Isoconazole nitrate in the treatment of tropical dermatomycoses. Mycoses (1994) 37(1-2):39-41.
113. DEL P, CUETARA S, IZQUIERDO I, VIDELA S et al.: A double-blind, randomized comparative trial: flutrimazole 1% solution versus bifonazole 1% solution once daily in dermatomycoses. Mycoses (1995) 38(9-10):395-403.
114. ALOMAR A, VIDELA S, DELGADILLO J, GICH I, IZQUIERDO I, FORN J: Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group. Dermatology (1995) 190(4):295-300.
115. FREDRIKSSON T: Treatment of dermatomycoses with topical tioconazole and miconazole. Dermatologica (1983) 166 Suppl.):114-119.
116. SAVIN RC: Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. J. Am. Acad. Dermatol. (1984) 10(5 Pt 1):824-830.
117. GIAM YC, RAJAN VS: Oral Ketoconazole- a new treatment for Tinea Versicolor. Singapore Med. J. (1984) 25(3):157-160.
118. BORELLI D: Treatment of pityriasis versicolor with ketoconazole. Rev. Infect. Dis. (1980) 2(4):592-595.
119. ALTERAS I, SANDBANK M, SEGAL R: Two years of follow-up of oral ketoconazole therapy in 60 cases of pityriasis versicolor. Dermatologica (1987) 175(3):142-144.
120. FERNANDEZ-NAVA HD, LAYA-CUADRA B, TIANCO EA: Comparison of single dose 400 mg versus 10-day 200 mg daily dose ketoconazole in the treatment of tinea versicolor. Int. J. Dermatol. (1997) 36 1):64-66.
121. GIAM YC, THAM SN: Ketoconazole in Tinea versicolor: is ten day therapy adequate? Singapore Med. J. (1987) 28(1):13-17.
122. DEL PALACIO HA, FRIAS-INIESTA J, GONZALEZ-VALLE O, BORGERS M, VAN CUTSEM J, CAUWENBERGH G: Itraconazole therapy in pityriasis versicolor. Br. J. Dermatol. (1986) 115(2):217-225.
123. DELESCLUSE J, CAUWENBERGH G, DEGREEF H: Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor. Br. J. Dermatol. (1986) 114(6):701-703.
124. PANCONESI E, DIFONZO E: Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Rev. Infect. Dis. (1987) 9(Suppl. 1):S109-S113.
125. ESTRADA RA: Itraconazole in pityriasis versicolor. Rev. Infect. Dis. (1987) 9(Suppl. 1):S128-S130.
126. MORALES-DORIA M: Pityriasis versicolor: efficacy of two five-day regimens of itraconazole. Rev. Infect. Dis. (1987) 9 Suppl. 1):S131-S133.
127. FAERGEMANN J: Treatment of pityriasis versicolor with itraconazole. Mykosen (1987) 30(1):44-47.
128. FAERGEMANN J: Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study. Mycoses (1988) 31(7):377-379.
129. ROSEEUW D, WILLEMSEN M, KINT RT, PEREMANS W, MERTENS RL, VAN CUTSEM J: Itraconazole in the treatment of superficial mycoses-a double-blind study versus placebo. Clin. Exp. Dermatol. (1990) 15(2):101-104.
130. FAERGEMANN J: Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm. Venereol. (1992) 72 1):74-75.
131. KOSE O: Fluconazole versus itraconazole in the treatment of tinea versicolor. Int. J. Dermatol. (1995) 34(7):498-499.
132. DEL PALACIO HA, DELGADO VS, MENENDEZ RF, RODRIGUEZ-NORIEGA BA: Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. Rev. Infect. Dis. (1987) 9(Suppl. 1):S121-S127.